في دراسة حديثة أجرتها مايو كلينك، وجد الباحثون أن معظم المرضى الذين وصِف لهم عدد أقل من العقاقير أفيونية المفعول بعد الجراحة كانوا قادرين على الحفاظ على مستويات مُرضية من الراحة بدون الحاجة إلى تكرار صرف الأدوية لاحقًا.
Em um estudo recente da Mayo Clinic, pesquisadores descobriram que a maioria dos pacientes que recebeu a prescrição de opioides depois da cirurgia foi capaz de manter níveis satisfatórios de conforto sem a necessidade de haver a renovação da receita posteriormente.
En un estudio reciente de Mayo Clinic, los investigadores descubrieron que la mayoría de los pacientes a los que se les recetaron menos opioides después de una cirugía pudieron mantener niveles satisfactorios de bienestar sin necesitar más resurtidos de prescripción luego.
The ability of cancer cells to metastasise, or spread from one part of the body to another, is one of the reasons why cancer can be extremely challenging to treat. However, the process that drives metastasis is complex and not fully understood.
SMU chemistry professor John Buynak and his team have received a $3.5 million, 5-year grant from the National Institutes of Health to design and synthesize new antibiotics to fight some of the deadliest and most clinically challenging infections of the 21st century – drug resistant strains of bacteria that cause tuberculosis and leprosy.
Researchers at Sylvester Comprehensive Cancer Center found that robot-assisted surgeries and new patient-care protocols are enabling lung cancer surgery patients to go home earlier, with less pain and almost always without a need for potentially addictive opioids.
Texas Tech researchers are taking a closer look at drug-resistant organisms and searching for new ways to attack them.
Researchers have invented a nano-thin superbug-slaying material that could one day be integrated into wound dressings and implants to prevent or heal bacterial infections.
Researchers have received a U.S. patent for a novel method to identify therapeutic agents to treat addiction. The invention, related to the fields of pharmacology, medicine, neurology and psychiatry, targets the protein MBLAC1, which the Blakely lab identified as the mammalian form of a gene the group first identified in worms as a modifier of signaling by the neurotransmitter dopamine.
Research from Michigan State University has shown that more than 100 strains of Campylobacter jejuni, a leading cause of foodborne illness, circulating in Michigan are resistant to at least one antibiotic.
Bees could become biomonitors, checking their neighbourhoods to determine how far antimicrobial resistance (AMR) has spread, according to research by Macquarie University scientists.
Breast cancers with mutations in the HER2 gene are initially sensitive to HER2 inhibitors like neratinib. However, most tumors eventually become resistant.
A new powerful antibiotic, isolated from bacteria that could not be studied before, seems capable to combat harmful bacteria and even multi-resistant ‘superbugs’.
Scientists at St. Jude Research Hospital unravel the mechanisms behind a key culprit in chemotherapy resistance.
Current methods can vastly overestimate the rates that malaria parasites are multiplying in an infected person’s blood, which has important implications for determining how harmful they could be to a host, according to a new report.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.
Bacteria draw from an arsenal of weapons to combat the drugs intended to kill them. Among the most prevalent of these weapons are ribosome-modifying enzymes. These enzymes are growing increasingly common, appearing worldwide in clinical samples in a range of drug-resistant bacteria.
“Back-to-school” season means earaches. Today, a team reports a single-use nanoscale system unlikely to generate resistance. It can kill an ear-infection-causing bacterium in animals with a compound like bleach, and it could someday be used in a gel. They will present their results at ACS Fall 2023.
Each year, over 670,000 people in Europe fall ill because of antibiotic-resistant pathogens, and 33,000 die from the infections.
The National Cancer Institute (NCI) has awarded a 5-year, $2.7 million grant to researchers at Sanford Burnham Prebys to investigate and elucidate the underlying cellular mechanisms that drive the most common form of breast cancer.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
